Please use this identifier to cite or link to this item:
Title: The Calculating Boluses on Multiple Daily Injections (CBMDI) study: A randomized controlled trial on the effect on metabolic control of adding a bolus calculator to multiple daily injections in people with type 1 diabetes.
Authors: Vallejo-Mora, María Del Rosario
Carreira-Soler, Mónica
Linares-Parrado, Francisca
Olveira, Gabriel
Rojo-Martínez, Gemma
Domínguez-López, Marta
Ruiz-de-Adana-Navas, María Soledad
González-Romero, María Stella
Keywords: HbA1c;bolus calculator;glycemic control;insulin therapy;type 1 diabetes
metadata.dc.subject.mesh: Adult
Blood Glucose
Diabetes Mellitus, Type 1
Drug Administration Schedule
Glycated Hemoglobin
Injections, Subcutaneous
Issue Date: 13-Apr-2016
Abstract: Although the insulin bolus calculator is increasingly being used by people with type 1 diabetes (T1D) on multiple daily injection (MDI) therapy, few studies have investigated its effects on glycemic control. The aim of this study was to determine whether adding this device to therapeutic intensification could further improve metabolic control. A 4-month randomized controlled clinical trial was performed comparing subjects undergoing therapeutic intensification and either using the bolus calculator (Cb group) or not (active control [Co] group). Metabolic control, fear of hypoglycemia, and treatment acceptance were evaluated. In all, 70 people completed the study (42 in the Cb group, 28 in the Co group). There was a significant decrease in HbA1c in both the Cb and Co groups (-7 mmol/mol [-0.7 %] vs -4 mmol/mol [-0.4 %], respectively). There were no significant differences in HbA1c at baseline or the end of the study, or in the decrease in HbA1c, glycemia, or changes in blood glucose levels at the end of the study between the two groups. There was a significant increase in the number of participants with good metabolic control (HbA1c In T1D, adding a bolus calculator to intensive MDI resulted in a significant improvement in metabolic control and slightly decreased the number of hypoglycemic episodes. Metabolic control also improved in the Co group.
metadata.dc.identifier.doi: 10.1111/1753-0407.12382
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.

This item is protected by original copyright

Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.